ArticleClinical neuropathology

Clinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma.

Matthias Preusser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.